Therapeuticsmd Inc (TXMD) Stock Price, Quote & News

Company Profile

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 561 961 1900

Website: www.therapeuticsmd.com

Address:

951 Yamato Road, Suite 220, Boca Raton, United States

Bio_Invest101 Mar. 2 at 7:34 PM

$TXMD So many deals done in so many creative ways in the past 12 months. What exactly Rubric Capital Wants to accomplish? Soon it might run out of best time https://www.businesswire.com/news/home/20260301356096/en/Rallybio-Corporation-and-Candid-Therapeutics-Announce-Merger-Agreement

0 · Reply

YPOJOB Feb. 26 at 10:22 PM

$TXMD Any news out there?

0 · Reply

Kobe2324 Feb. 20 at 7:14 PM

$TXMD if history repeats itself I anticipate a spike in volume in the next 5-6 trading days

0 · Reply

YPOJOB Feb. 20 at 1:59 AM

$TXMD Patience is ____________with this investment. Either we all are ________or _______. I trully think about this and change my answers to the blanks. Haha. Just trying to have fun today. I am still bullish but_______. I am still bearish but_______.

0 · Reply

hiTHit Feb. 17 at 4:14 PM

$TXMD I'm wearing headphones here; I don't want to listen to or interact with anyone. I will leave as soon as my shift here is over.🤓

0 · Reply

CapitalTrajectory Feb. 17 at 1:03 PM

$TXMD Women's health pharma; commercial challenges.

0 · Reply

trendricky Feb. 17 at 8:27 AM

$TXMD Women's health pharma; commercial challenges

0 · Reply

NYCAristocrat Feb. 13 at 6:13 PM

$TXMD 500 shares dropped this to 2.35 lol

0 · Reply

brenbto Feb. 13 at 4:45 PM

$TXMD https://x.com/AnotherBio/status/2022338669345173883?s=20

0 · Reply

Kobe2324 Feb. 12 at 1:10 PM

$TXMD what are the odds that news comes on earnings day vs random day?

2 · Reply

TherapeuticsMD Announces Third Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 7 months ago

TherapeuticsMD Announces Second Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 10 months ago

TherapeuticsMD Announces First Quarter 2025 Financial Results

Mar 27, 2025, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces Full Year 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 1 year ago

TherapeuticsMD Announces Third Quarter 2024 Financial Results

Aug 26, 2024, 7:36 AM EDT - 1 year ago

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

Aug 12, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces Second Quarter 2024 Financial Results

May 10, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces First Quarter 2024 Financial Results

Mar 29, 2024, 4:00 PM EDT - 2 years ago

TherapeuticsMD Announces Full Year 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 2 years ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Aug 14, 2023, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Second Quarter 2023 Financial Results

May 23, 2023, 9:00 AM EDT - 3 years ago

TherapeuticsMD: From Fallen And Forgotten To Cash Cow

May 15, 2023, 4:05 PM EDT - 3 years ago

TherapeuticsMD Announces First Quarter 2023 Financial Results

Apr 7, 2023, 4:01 PM EDT - 3 years ago

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

Jan 3, 2023, 6:50 AM EST - 3 years ago

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

Dec 4, 2022, 6:00 PM EST - 3 years ago

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

Nov 14, 2022, 4:05 PM EST - 3 years ago

TherapeuticsMD Announces Third Quarter 2022 Financial Results

Oct 31, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Additional $7 Million Private Placement

Oct 3, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces $7 Million Private Placement

Sep 12, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

Aug 15, 2022, 9:46 AM EDT - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q2 2022 Results - Earnings Call Transcript

Aug 15, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Second Quarter 2022 Financial Results

Aug 8, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

Aug 1, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Jul 13, 2022, 9:59 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Sinking Today?

Jul 13, 2022, 8:25 AM EDT - 3 years ago

TherapeuticsMD's stock falls 41% after tender offer expires

Jul 13, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Expiration of Tender Offer

Jul 6, 2022, 6:09 AM EDT - 3 years ago

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

Jun 21, 2022, 12:01 PM EDT - 4 years ago

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

WEBR

Jun 16, 2022, 2:43 PM EDT - 4 years ago

TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback

Jun 13, 2022, 10:49 AM EDT - 4 years ago

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

BEEM

Jun 6, 2022, 4:05 PM EDT - 4 years ago

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

May 31, 2022, 7:34 PM EDT - 4 years ago

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

May 31, 2022, 1:57 PM EDT - 4 years ago

Here is why TherapeuticsMD jumped 300%

May 31, 2022, 10:12 AM EDT - 4 years ago

Why TherapeuticsMD Stock Is Soaring Today

May 31, 2022, 6:00 AM EDT - 4 years ago

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

May 20, 2022, 10:54 AM EDT - 4 years ago

Why TherapeuticsMD Shares Are Trading Higher Today

May 20, 2022, 9:43 AM EDT - 4 years ago

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

May 16, 2022, 8:07 PM EDT - 4 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call Transcript

May 16, 2022, 4:05 PM EDT - 4 years ago

TherapeuticsMD Announces First Quarter 2022 Financial Results

May 10, 2022, 4:05 PM EDT - 4 years ago

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

Apr 14, 2022, 4:15 PM EDT - 4 years ago

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

GDRX

Mar 14, 2022, 8:39 AM EDT - 4 years ago

TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business

Mar 10, 2022, 10:35 AM EST - 4 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd On Q4 2021 Results - Earnings Call Transcript

Mar 10, 2022, 6:50 AM EST - 4 years ago

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Mar 7, 2022, 9:38 AM EST - 4 years ago

Why TherapeuticsMD Shares Are Soaring Today

Bio_Invest101 Mar. 2 at 7:34 PM

0 · Reply

YPOJOB Feb. 26 at 10:22 PM

$TXMD Any news out there?

0 · Reply

Kobe2324 Feb. 20 at 7:14 PM

$TXMD if history repeats itself I anticipate a spike in volume in the next 5-6 trading days

0 · Reply

YPOJOB Feb. 20 at 1:59 AM

0 · Reply

hiTHit Feb. 17 at 4:14 PM

$TXMD I'm wearing headphones here; I don't want to listen to or interact with anyone. I will leave as soon as my shift here is over.🤓

0 · Reply

CapitalTrajectory Feb. 17 at 1:03 PM

$TXMD Women's health pharma; commercial challenges.

0 · Reply

trendricky Feb. 17 at 8:27 AM

$TXMD Women's health pharma; commercial challenges

0 · Reply

NYCAristocrat Feb. 13 at 6:13 PM

$TXMD 500 shares dropped this to 2.35 lol

0 · Reply

brenbto Feb. 13 at 4:45 PM

$TXMD https://x.com/AnotherBio/status/2022338669345173883?s=20

0 · Reply

Kobe2324 Feb. 12 at 1:10 PM

$TXMD what are the odds that news comes on earnings day vs random day?

2 · Reply

jfer333 Feb. 11 at 2:10 AM

$TXMD For anyone wondering why Rubric became the parent… here’s the blueprint: 1️⃣ Buy broken asset cheap 2️⃣ Stabilize balance sheet 3️⃣ Clean up liabilities (lawsuit, legacy issues) 4️⃣ Add capacity (640M share authorization) 5️⃣ Roll in new assets / platform 6️⃣ Rebrand / restructure business model 7️⃣ Exit at scale 💰 This isn’t a side hustle. This is how PE/distressed funds build multi-baggers. We’re sitting between Steps 4 → 5 right now.

1 · Reply

NYCAristocrat Feb. 9 at 5:52 PM

$TXMD we are close to a deal here. I think it wraps up end of 1Q, 2Q the latest

0 · Reply

ButterflyBets Feb. 9 at 3:10 PM

$TXMD Women's health pharmaceutical; has faced commercial execution challenges.

0 · Reply

Chazzzz1 Feb. 6 at 11:34 PM

$TXMD Big boys will play with this stock until they get what they want, which is a HUGE pop for TXMD. Just look at who is still involved with this nightmare.

0 · Reply

jfer333 Feb. 6 at 2:44 AM

$TXMD Legal Silence Speaks Volumes We were supposed to get a court update by Nov 25 in the $TXMD v. Mayne Pharma breach of contract case. It’s now been 60+ days — and still, no docket movement. If the judge was going to deny the motion or move the case forward, we’d have seen it already. This kind of delay usually means one thing: 🤝 Settlement talks are underway 💼 Negotiations are happening behind the scenes 🔏 The court is holding back to let them work it out privately Rubric wins either way. TXMD has leverage. Mayne’s options are shrinking. A deal may already be in the works. Sometimes the quietest part of the chart is the most explosive.

1 · Reply

OfficialStocktwitsUser Feb. 5 at 1:58 AM

$TXMD RSI: 52.97, MACD: 0.1151 Vol: 0.20, MA20: 2.29, MA50: 1.93 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

vijalp9 Feb. 5 at 12:58 AM

$TXMD Some big sells hit the tape today. Looks like a 10k share block (short maybe?) at 12:40P EST dropped the price from 2.25 down to 2.14 momentarily. Been a bit too quiet lately.

0 · Reply

Kobe2324 Feb. 3 at 7:47 PM

$TXMD come on finalize whatever thing you are going to do.

0 · Reply

Usc1997 Jan. 31 at 9:23 AM

$TXMD is like that girl in college who was such a tease. Just when you think you have a chance, it all comes crashing back down to reality. TXMD is going to thrash between 1.50 and 2.50 for years.

1 · Reply

prismmarketview Jan. 29 at 5:31 PM

PRISM Mid-Day Movers: Cybersecurity and Oil & Gas are Today’s Leaders Sangamo ( $SGMO) is bouncing 30–35% as traders rotate back into its neurology‑focused genomic‑medicine platform and big‑pharma‑backed CNS pipeline, while Battalion Oil ( $BATL) rips another 25–30% on momentum tied to its Monument Draw gas‑processing and oil‑output upgrade. Other Notable Movers: Innodata ( $INOD) up 13% TherapeuticsMD, Inc. ( $TXMD) up 10% Fractyl Health ( $GUTS) down -66% https://prismmarketview.com/prism-mid-day-movers-cybersecurity-and-oil-gas-are-todays-leaders/

0 · Reply

jfer333 Jan. 29 at 4:32 PM

$TXMD sold shares at $2.80 … buy them back plus more at $2.15. Trust in your Bollinger bands and RSI indicators. They will be right 95% of the time.

3 · Reply

Kobe2324 Jan. 29 at 2:41 PM

$TXMD I think this had been the trend of pullbacks on our way up. Since November we had had increasing volume with movement upwards followed by drops, by the line is moving up. In November we peaked at 2.1 only to drop to 1.45 the next day. Only to rebound a few days later. We ran sideways in December and January has been nice. Even if we run sideways I anticipate another run into earnings.

1 · Reply

Market Cap	26.16M
Revenue (ttm)	1.76M
Net Income (ttm)	-2.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-123.86%
Debt to Equity Ratio	0.00

Volume	14,072
Avg Vol	94,208
Day's Range	N/A - N/A
Shares Out	11.57M
Stochastic %K	42%
Beta	0.52
Analysts	Strong Buy
Price Target	$5.00